Current and historical daily PE Ratio for MannKind Corp (
) from 2004 to Jun 02 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. MannKind stock (MNKD) PE ratio as of Jun 02 2024 is 116.75.
More Details
MannKind Corp (MNKD) PE Ratio (TTM) Chart
MannKind Corp (MNKD) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 1241
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| MannKind PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-03 | 116.8 | 2024-03-28 | 113.3 |
| 2024-05-31 | 116.8 | 2024-03-27 | At Loss |
| 2024-05-30 | 112.5 | 2024-03-26 | At Loss |
| 2024-05-29 | 113.3 | 2024-03-25 | At Loss |
| 2024-05-28 | 115.8 | 2024-03-22 | At Loss |
| 2024-05-24 | 119.5 | 2024-03-21 | At Loss |
| 2024-05-23 | 120.5 | 2024-03-20 | At Loss |
| 2024-05-22 | 120.5 | 2024-03-19 | At Loss |
| 2024-05-21 | 118.5 | 2024-03-18 | At Loss |
| 2024-05-20 | 117.5 | 2024-03-15 | At Loss |
| 2024-05-17 | 114.8 | 2024-03-14 | At Loss |
| 2024-05-16 | 114.8 | 2024-03-13 | At Loss |
| 2024-05-15 | 111.3 | 2024-03-12 | At Loss |
| 2024-05-14 | 112.5 | 2024-03-11 | At Loss |
| 2024-05-13 | 110.3 | 2024-03-08 | At Loss |
| 2024-05-10 | 108.0 | 2024-03-07 | At Loss |
| 2024-05-09 | 107.8 | 2024-03-06 | At Loss |
| 2024-05-08 | 110.0 | 2024-03-05 | At Loss |
| 2024-05-07 | 111.8 | 2024-03-04 | At Loss |
| 2024-05-06 | 110.0 | 2024-03-01 | At Loss |
| 2024-05-03 | 109.8 | 2024-02-29 | At Loss |
| 2024-05-02 | 109.5 | 2024-02-28 | At Loss |
| 2024-05-01 | 108.5 | 2024-02-27 | At Loss |
| 2024-04-30 | 102.8 | 2024-02-26 | At Loss |
| 2024-04-29 | 106.5 | 2024-02-23 | At Loss |
| 2024-04-26 | 105.8 | 2024-02-22 | At Loss |
| 2024-04-25 | 104.5 | 2024-02-21 | At Loss |
| 2024-04-24 | 104.8 | 2024-02-20 | At Loss |
| 2024-04-23 | 104.0 | 2024-02-16 | At Loss |
| 2024-04-22 | 102.8 | 2024-02-15 | At Loss |
| 2024-04-19 | 104.5 | 2024-02-14 | At Loss |
| 2024-04-18 | 102.0 | 2024-02-13 | At Loss |
| 2024-04-17 | 102.5 | 2024-02-12 | At Loss |
| 2024-04-16 | 101.3 | 2024-02-09 | At Loss |
| 2024-04-15 | 103.0 | 2024-02-08 | At Loss |
| 2024-04-12 | 103.8 | 2024-02-07 | At Loss |
| 2024-04-11 | 107.5 | 2024-02-06 | At Loss |
| 2024-04-10 | 106.0 | 2024-02-05 | At Loss |
| 2024-04-09 | 111.0 | 2024-02-02 | At Loss |
| 2024-04-08 | 113.8 | 2024-02-01 | At Loss |
| 2024-04-05 | 111.0 | 2024-01-31 | At Loss |
| 2024-04-04 | 107.8 | 2024-01-30 | At Loss |
| 2024-04-03 | 110.8 | 2024-01-29 | At Loss |
| 2024-04-02 | 107.8 | 2024-01-26 | At Loss |
| 2024-04-01 | 108.5 | 2024-01-25 | At Loss |
MannKind Corp (MNKD) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
MannKind Corp
NAICS : 325412
SIC : 2834
ISIN : US56400P7069
Share Class Description:
MNKD: Ordinary SharesDescription
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers